Everolimus plus exemestane for hormonereceptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
Address: B 117 Okhla industries Area Phase -I New Delhi / B-289, Okhla industrial Area, phase-1, New Delhi, 110020, India Vendor Details Country of origin: India 949 MRP 127926% off Save more with additional offers Flat Rs.150 on a Min Transaction of Rs.1000
The four amino acid substitutions in CJC-1295 without DAC at positions 2, 8, 15, and 27 were deliberately selected to prevent cleavage by DPP-4 and other endopeptidases while preserving full GHRH receptor selectivity
Book your consultation today
The data were analysed and processed using the cloud platform NovoMagic
Refine Her is designed for women in their 30s through 60s